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Abstract Skin metastatization of internal cancers are rare
and a few studies are available analyzing its clinicopatho-
logical features. The reported incidence of skin metastasis is
influenced by two factors: the relative proportion of cancers
covered by skin in the various cohorts and the large differ-
ences in the prevalences of various cancer types.
Futhermore, the anatomical distribution of skin metastases
of various cancer types is aslo not well known. Therefore we
have collected a skin metastasis cohort of biopsy and
authopsy cases (n=80) from the archive of our department
and analysed its clinicopathologic features. The adjusted
skin metastasis prevalence data of various inner cancers
indicated that kidney-, lung- and colorectal cancers have a
strong positive preference for skin metastatisation while
pancreatic cancer has a negative one. We have provided
evidences that lower gastrointestinal- and genitourinary can-
cers preferred infradiaphragmatic skin regions unlike upper
gastrointestinal cancers while lung- and kidney cancers pre-
ferred supradiaphragmatic regions. We have also detected
that ventral skin regional metastasis is slightly more preva-
lent irrespective of the cancer type. Our study provide the
first statistical data for the variations in skin preference of
metastatisation among various cancer types as well as for
the significant variations in their regional distributions.
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Introduction
Skin is a rare location for distant metastases of malignant
tumors especially from internal organs, its prevalence however
has grown, linked to the longer survival of patients by reason
of more efficient oncological therapies. Compared to the
sixties [1], skin metastasis prevalence has changed from 1 %
to 5–10 % according to newer studies [2], while the more
objective autopsy studies show a lower prevalence (1–4 %).
Skin metastases generally develop in the late, disseminated
stage, but may also be the first clinical manifestation of an
asymptomatically progressing cancer [3–5]. The clinical pic-
ture of skin metastasis is highly variable, therefore presenting a
serious differential diagnostic problem for dermatologists and
oncologists. The most common cancers giving skin metastasis
are melanoma in men followed by lung-, colorectal-, oral- and
kidney cancers. In woman the most frequent primary of skin
metastasis is breast cancer followed by colorectal-, lung-,
kidney-, ovarian cancers and malignant melanoma [3–5].
There are two problems with these statistics. Concerning
“real” skin metastasis as distant organ metastasis, the tumors
which may involve the skin either as part of the local invasion
process (melanoma, breast cancer) or during the locoregional
lymphatic dissemination have to be discriminated from those
tumors in which no such mechanisms are known i.e. inner
organ cancers such as lung-, colorectal-, kidney cancer etc. The
other problem is the fact that incidence of skin metastases of
inner organ cancers is influenced by the relative prevalence of
these cancers. Another catch is that one of the most common
locations of skin metastasis is the surgical scar, where local
iatrogenic cancer cell contamination or preferential wound-
homing are both possible alternative mechanisms [6–8].
The present study summarizes the clinicopathological fea-
tures of skin metastases diagnosed at our department. We have
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attempted to select only those cases in which local
confounding processes can be excluded for skin-
involvement and analysed distant metastasis exclusively. Fur-
ther, we focused on the question whether there is any
relationship between the location of the primary tumor
and its skin metastasis pattern.
Material and Methods
Biopsy samples and data were collected retrospectively
from the archives of the 2nd Department of Pathology,
Semmelweis University between 1993 and 2010. Specimens
included surgical biopsy, fine needle aspiration cytology and
autopsy samples. In case of the former two sampling
methods, clinical data were collected (if available) such as
location of skin metastasis, interval between diagnosis of the
primary tumor and skin metastasis (less than 1 month inter-
val was defined as a synchronous occurrence), and surgical
treatment of the primary tumor. Furthermore, among the
autopsy cases the location of all metastases was determined.
Diagnosis of the primary tumor was based on either histo-
logical or cytological examination in every case. The origin
of skin metastases was proved by obvious histo- or
cytomorphological features, immunohisto- or cytochemistry
was performed only in ambiguous cases. The absolute prev-
alence of skin metastases was determined by using only the
autopsy group data, while the organ-specific relative preva-
lence of skin metastases was also calculated based on over-
all cancer mortality statistics in our autopsy database. The
protocol was approved by the local ethical comittee
(TUKEB114/2012).
The study includes only skin metastasis from solid ma-
lignancies of those internal organs which have neither direct
anatomical nor lymphatic or vascular connection with the
skin. Therefore, hematologic tumors, primary skin tumors,
breast and head-neck (pharynx, larynx and thyroid) cancers
were excluded. Surgical wound metastases were also
excluded.
Differential diagnostic immunohistochemical reactions
were performed on paraffin embedded tissue samples using
primary antibodies including pan cytokeratin (AE1-AE3,
DAKO), cytokeratin 7 (DAKO), cytokeratin 20 (DAKO),
vimentin (DAKO), thyroid transcription factor-1 (Bio-
Genex), chromogranin (DAKO), synaptophysin (Bio-Genex)
and prostate specific antigene (DAKO). Immunocytochemical
reactions were performed on unstained smears using the
primary antibodies listed above. Reactions were carried
out in Ventana ES automatic immunostainer (Ventana
Medical Systems, Inc.; Tucson, AZ) using avidin-biotin
peroxidase technique and diaminobenzidine as chromo-
gen according to the manufacturer’s protocol (iView
DAB Detection Kit; Ventana Medical Systems).
Further immunohistochemical reactions were performed
on the available paraffin blocks to demonstrate lymphatic or
hematogenic invasion in order to conclude the possible
pathomechanism of the skin metastasis. Endothelial cells
were detected by CD 31, CD 34 , and D-240 (DAKO)
antibodies.
Comparisons between the distribution of skin metastases
of different primary tumors were assessed by chi-square test.
Differences were considered to be significant at p<0.05.
Results
Our cohort comprised 80 patients (43 men and 37 women)
diagnosed with skin metastases either with biopsy or at
authopsy were aged from 33 to 88 years (mean 62.2 years).
We have calculated the prevalence of skin metastases from
internal cancers 0.9 % based on our authopsy records (13
cases/1449). In 34 cases (43 %) the skin metastasis was
diagnosed simultaneously with the primary tumor or as the
first lesion of the patient’s neoplastic disease. Among pa-
tients with known malignancy the skin metastasis developed
2 to 154 months after the initial diagnosis (mean
23.6 months). The primary tumor was surgically resected
in 42 cases (53 %) synchronously with the skin metastasis or
before the development of the skin metastasis. The most
common biopsy method was fine needle aspiration in 40
cases, surgical local resection was performed in 29 cases,
autopsy sampling was done in 13 cases. Clinicopathological
features of our cohort is summarized in Table 1.
The most common location of primary tumors giving
skin metastasis was the large bowel, followed by lung,
upper gastrointestinal tract, kidney, liver, ovary, uterus,
prostate and urinary vesicle. Since incidence of various
primary tumors is very different we made an attempt to
correct skin metastasis prevalence data for the relative inci-
dence of the primary tumors based on incidence data of our
authopsies. This analysis indicated that kidney cancer was
the most and pancreatic cancer the less frequent visceral
malignancy metastasizing to the skin (Fig. 1.). It is of note
that it seems based on these data that lung- and colorectal
cancer also has a moderate positive while liver cancer has a
moderate negative prefrence for skin metastasis.
The exact locations (based on available clinical data in 74
cases) of skin metastases are shown on Fig. 2. The most
commonly affected area was the abdominal skin region (34
cases), followed by the anterior chest and head and neck
with 15 cases each, the back in 7 cases, the extremities in 5
cases and the genitals in 1 case. Our data showed striking
differences between various cancer types in relation to the
localization of their skin metastases. Almost half of the lung
cancer skin metastases were in chest skin and a third located
in the head and neck region (Fig. 2b). Contrary to this
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pattern, two thirds of the colorectal cancer skin metastases
were localized to the abdominal skin and the rest equally
distributed in the skin of the head and neck, chest and upper
extremity (Fig. 2a). When colon and rectal cancers were
separated it became evident that although colon cancer fol-
lows the abdominal predominance (13/18, 72.2 %), rectal
cancer did not (2/4,50 %) in our series (Fig. 2a). In our cohort
the skin metastasis distribution of both liver and kidney can-
cers followed the lung cancer pattern (Fig. 2b, d).
Ipsilateral and controlateral skin metastases were equal in
number among the malignancies of paired organs and the
large bowel. We were looking for cancer type-specific dif-
ferences in anatomical distribution of skin metastases and
statistically analyzed two issues: the variation in supra-
versus infradiaphragmatic localization and the ventral ver-
sus dorsal distributions in our cohort. This analysis provided
statistical evidence for the cancer type differences in the
location of skin metastases relative to the diaphragm. Sim-
ilarly to some previous reports [3–5], lower gastrointestinal
and genitourinary cancers preferred the infradiaphragmatic
skin regions unlike upper gastrointestinal cancers, while
lung and kidney cancers preferred the supradiaphragmatic
skin regions. Our data also indicated that in harmony with
some previous reports, ventral skin region metastases are the
most common, irrespective of cancer type (Table 2).
To explore the possible pathomechanism leading to skin
metastatization, we have tested lymphovascular invasion rate
in available metastatic samples [9] using immunohistochem-
istry to differentiate between blood (CD31+/CD34+) and
lymphatic (D-240+) vessels. Definitive vascular invasion
was proved only in 4 cases (28.6 %). Immunohistochemical
Table 1 Clinicopathological characteristics of the skin metastasis cohort
Localisation of
primary tumor
All Lower gastro-
intestinal tract
Lung Upper gastro-
intestinal tract
Kidney Liver Gynecologic Pancreas Lower
urinary
tract
Patients
Number of cases 80 27 21 9 7 6 5 3 2
Age 62,2
(33–89)
61
(36–80)
61,2
(41–89)
62,9
(33–88)
64,1
(59–76)
54,7
(33–71)
60,4
(34–77)
75
(68–80)
77,5
(74–81)
Sex(male;female) 43:37 13:14 11:10 6:3 5:2 5:1 2:1 1:1
Biopsy method
Surgical excision 27 12 2 3 4 3 3 1 1
Fine needle cytology 40 12 11 5 2 3 2 1 1
Autopsy 13 3 8 1 1 0 0 1 0
Diagnosis of
primary tumor
Unknown primary
tumor or synchron
primary tumor and
skin metastasis
35 5 17 3 4 2 2 1 0
Known primary tumor 45 22 4 6 3 4 3 2 2
Interval between the
diagnosis of primary
tumor and skin
metastasis (months)
23,6(2–154) 23(2–108) 13,7(10–17) 15,4(6–26) 53(2–154) 9,3(4–14) 24 10 48
Surgical therapy of
primary tumor
Resection 42 24 0 5 6 3 4 0 1
Inoperable 38 3 21 4 1 3 1 3 1
Fig. 1 Relative frequences of skin metastases (n=80, this study) of
various cancer types. Relative frequency calculated according to local
cancer prevalences (n=1443), <1=negative preference, >1=positive
preference for skin metastasis formation
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detection of different types of endothelium showed 3 lym-
phatic (21.5 %) and 1 blood vessel invasions (7.1 %), the
former in lung and colon adenocarcinoma, the latter in a colon
adenocarcinoma case (Fig. 3a–d). As another possible mech-
anism leading to skin metastasis, we have tested peripheral
nerve involvement in our cohort where histological samples
Fig. 2 Anatomical distribution
of skin metastases (n=74, this
study). a Lower gastrointestinal
cancers. Colon=black, rectal=
white, b Lung cancer, c Upper
gastrointestinal cancers. Black=
gastric cancer, red=liver cancer,
white=esophageal, yellow=
pancreatic, d Urogenital
cancers. Black=kidney, red=
ovarian, vaginal=yellow,
prostatic=white
Table 2 Regional distribution
of skin metastases
Significance was tested on paired
data using chi2 test
aOverall distribution of ipsi/
controlaterally located cutaneous
metastases of 10 large bowel, 7
lung, 3 kidney carcinoma cases
Lokalization of skin metastasis
Supradiaphramatic (n/%) Infradiaphragmatic (n/%)
Localisation of the primary tumor p
Lower gastrointestinal 7 (25,9 %) 20 (74,1 %)
Lung 19 (90,5 %) 2 (9,5 %)
Upper gastrointestinal 3 (33,3 %) 6 (66,7 %)
Kidney 6 (85,8 %) 1 (14,2 %)
Liver 3 (60 %) 2 (40 %)
Gynecologic 0 5 (100 %)
All 38 (56,7 %) 29 (43,3 %) p=0.005
Ventral Dorsal
Lower gastrointestinal 26 (96,3 %) 1 (3,7 %)
Lung 17 (81 %) 4 (19 %)
Upper gastrointestinal 6 (85,8 %) 1 (14,2 %)
Kidney 6 (75 %) 2 (25 %)
Liver 4 (57,1 %) 3 (42,9 %)
All 61 (84.7 %) 11( 15.3 %) p=0.228
Ipsilateral Controlateral
Alla 9 (45 %) 11 (55 %) p=0,968
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were obtained but none of them contained nerve tissue
excluding the possibility of perineural spreading (data
not shown).
Discussion
Many physicians consider skin alterations a frequent mani-
festation of internal disease, at the same time, neoplastic
diseases rarely spread to the skin particularly from internal
organs [6, 10–12]. In our study autopsies revealed only less
than 1 % prevalence of skin metastasis among gastrointes-
tinal, lung, hepatobiliary and urogentital tract cancers. This
finding corresponds with the lower margin of the literaturary
data, however exclusion of cancer types commonly giving
skin metastases, such as breast and head & neck tumors,
must be taken into account in this setting. Lung and breast
cancers are considered to have the greatest tendency to give
skin metastasis [7]. Our results showed the largest number
of skin metastases among colorectal cancers, but it should
be noted that this overrepresentation could be a result of our
principally gastrointestinal profiled clinical departments.
The skin metastases of breast cancer cases were not included
in this study, however the number of these cases exceeded
one hundred at our institute. We also assessed the relative
prevalence of skin metastases of visceral organs providing a
scale which shows the affinity of different cancers for me-
tastasizing to the skin. Interestingly, kidney cancer was
found to have the biggest potential to form skin metastasis,
followed by lung and colon cancers. On the other hand,
gastric, liver and pancreas cancers have less probality to
spread into the skin. These differences between the cutane-
ous metastatic potential presume a specific homing
mechanism in the skin rather than a difference either in
vascular anatomy or in the ability of vascular invasion of
the given cancer types.
Skin metastases generally develop in the end stage of
neoplastic disease, after the primary tumor has been clini-
cally detected, but some tumor types—most frequently lung
cancer—could remain occult until presentation of the skin
manifestation [8, 13]. Our data revealed that 43 % of pa-
tients presented with skin metastasis as the first or synchro-
nous clinical presentation of the neoplastic disease which is
much higher compared to the proportion of 22-23 %
reported in former studies. The interval between diagnosis
of primary tumor and development of skin metastasis varied
in wide range from some weeks to more than a decade with
the longest being 13 years in one case. This patient
underwent nephrectomy and died of multiple brain and lung
metastases which developed parallel with the skin metasta-
sis. In our study the mean latency was 23.6 months, in
concordance with the literature. Correct survival data were
unavailable for most of our patients, prognosis after skin
metastasis is very poor with only 7.5 months life expectan-
cy, according to the literature [10]. Long term survival after
surgical excision of skin metastasis was described only in a
case of solitary skin metastasis of renal cell carcinoma [14].
With regard to metastasis pattern to other distant loca-
tions we did not find any definable correlation in the autop-
sy cases. All kinds of distant metastasis patterns could be
revealed from brain to bones. Interestingly, only one case of
pancreatic cancer with regional lymph node metastasis did
not progress to any distant organ, but the skin.
Skin metastasis of visceral organs could be logically
assumed as a result of hematogenic rather than lymphotic
spread of tumor cells. Blood circulation dependent tumor
Fig. 3 Detection of
lymphovascular invasion in
skin metastases. a negative CD
31 and b positive D-240
reaction in lymphovascular
invasion of a lung cancer skin
metastasis (200x). c positive
CD-31 and d negative D-240
reaction in hematogenic
invasion of a colon cancer skin
metastasis (200x)
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spreading would indicate a randomly distributed skin me-
tastasis pattern, but there is clear evidence that most visceral
tumors have preferred skin regions for metastasization. We
also concluded that on one hand, some visceral cancer types
give metastases into the vicinity of the organ, such as lung
cancer with mainly supradiaphragmatic, colorectal cancer
with mainly subdiaphragmatic and genitourinary cancers
with lower abdominal site skin metastases. Strong signifi-
cant relationship was found between the supra- and
subdiaphragmatic distributions of skin metastases of differ-
ent origin. These group of cancers may represent the lym-
phatic way of metastasise to the skin. At the same time, it is
more difficult to understand why these kinds of skin metas-
tases do not respect the laterality of the primary tumor in
contrast to the regional lymph node metastases of the same
organs. On the other hand, the second group of visceral
cancers metastasizes to more distant skin regions may be
due to hematogenous way of metastasization. We found
such tumors with totally random skin metastasis distribu-
tion, e.g. liver cancer, while there is still a particular skin
region preference in this group, e.g. the head&neck location
in kidney cancer cases. This phenomenon could be another
argument favouring the role of some “homing” mechanism
which determines the terminal point of circulating tumor
cells in the skin tissue.
Definitive vascular invasion was proved only in four
cases. Immunohistochemical detection of different types of
endothelium showed three lymphatic and one hematogenic
vessel invasion, the former in lung and colon adenocarcino-
ma, the latter in a colon adenocarcinoma case. Lymphatic
invasion, however, could be a secondary infiltration pattern
after the development of the skin colony of the tumor cells.
The blood supply of the skin is derived from the subclavian
and external carotid branches on the head&neck, from the
spinal arteries on the trunk region and from the arteries of
extremities. We could not find any data on a direct connection
between blood or lymphatic vessels of the skin and the vis-
cerals, therefore the simple migration of tumor cells into the
skin, via the regional lymphatic or blood vessels seems un-
likely. One well known exception exists, namely the
periumbilical region which remains to be linked with the
abdominal viscera via the umbilical artery. This phenomenon
could explain the development of the so called Sister Mary
Joseph’s nodule, which is the metastatic tumor of the umbili-
cus deriving commonly from the abdominal organs, frequent-
ly associated with peritoneal carcinosis [7, 9].
In summary, skin metastases from visceral malignancies
are rare with an autopsy-based prevalence less than 1 % in
our study, compared to the much higher proportion with
cancers developing in organs with rich lymphatic connec-
tions with the skin e.g. breast or head&neck tumors. We also
concluded that visceral cancer types have largely different
cutaneous metastatic ability. As regards clinical signifi-
cance, on the one hand skin metastasis can develop as a
first sign of an asymptomatic neoplastic disease, raising
a challenging differential diagnostic problem for derma-
tologists, whereas on the other hand, from an oncolo-
gist’s point of view, skin metastasis indicates a very
poor prognosis for the patient’s managed cancer. The
distribution of skin metastases is not random, our results
fortified that most of the visceral tumors have favoured
skin regions to metastasize, however the exact explana-
tion of this phenomenon is still obscure. In a clinical
setting, this characteristic pattern could help to plan
further diagnostic procedures in case of unknown pri-
mary tumors.
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